Compare LCTX & SPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LCTX | SPCE |
|---|---|---|
| Founded | 1990 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 255.4M | 331.6M |
| IPO Year | 1996 | 2017 |
| Metric | LCTX | SPCE |
|---|---|---|
| Price | $1.05 | $3.33 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 5 |
| Target Price | ★ $6.25 | $3.06 |
| AVG Volume (30 Days) | 965.0K | ★ 4.9M |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 60.84 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $14,556,000.00 | $1,544,000.00 |
| Revenue This Year | $109.40 | $2,270.73 |
| Revenue Next Year | N/A | $880.03 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 53.24 | N/A |
| 52 Week Low | $1.00 | $2.13 |
| 52 Week High | $2.09 | $8.90 |
| Indicator | LCTX | SPCE |
|---|---|---|
| Relative Strength Index (RSI) | 39.23 | 60.57 |
| Support Level | N/A | $2.85 |
| Resistance Level | $1.18 | $3.29 |
| Average True Range (ATR) | 0.05 | 0.16 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 6.25 | 78.53 |
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.
Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.